1. Home
  2. RANI vs SXTC Comparison

RANI vs SXTC Comparison

Compare RANI & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

SELL

Current Price

$0.68

Market Cap

84.6M

Sector

Health Care

ML Signal

SELL

Logo China SXT Pharmaceuticals Inc.

SXTC

China SXT Pharmaceuticals Inc.

HOLD

Current Price

$0.07

Market Cap

92.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
SXTC
Founded
2012
2005
Country
United States
China
Employees
69
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
92.9M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
RANI
SXTC
Price
$0.68
$0.07
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $7.20
N/A
AVG Volume (30 Days)
535.7K
★ 14.2M
Earning Date
11-05-2026
08-19-2019
Dividend Yield
N/A
N/A
EPS Growth
★ 57.14
N/A
EPS
N/A
★ N/A
Revenue
★ $1,633,000.00
N/A
Revenue This Year
$283.19
N/A
Revenue Next Year
$5.99
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 58.85
N/A
52 Week Low
$0.46
$0.03
52 Week High
$3.87
$9.59

Technical Indicators

Market Signals
Indicator
RANI
SXTC
Relative Strength Index (RSI) 32.61 31.26
Support Level $0.61 $0.04
Resistance Level $0.85 $2.59
Average True Range (ATR) 0.05 0.92
MACD -0.01 -0.28
Stochastic Oscillator 2.99 0.06

Price Performance

Historical Comparison
RANI
SXTC

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: